$22.30
+0.26(1.16%)
Mkt Cap $2.8B
$7.14
$23.19
52-Week Range
At a Glance
AI-generated10x Genomics, Inc.
Revenue breakdown: Product And Service Revenue (33.4%), Consumables (27.1%), Single Cell Consumables (21.1%).
8-K
10x Genomics, Inc. reported its fourth quarter and full year 2025 financial results, including revenue of $166.0 million for Q4 2025 and $642.8 million for the full year, and provided 2026 revenue guidance of $600 million to $625 million. The company also announced strategic partnerships with the Cancer Research Institute, PharosAI, Dana-Farber Cancer Institute, and Brigham & Women's Hospital to advance cancer and autoimmune disease research.$2.8B
Market Cap
$646M
Revenue
-$44M
Net Income
Employees1,306
Fundamentals
How The Business Makes Money
Revenue by Segment
Product And Service Revenue33.4%($1.8B)
Consumables27.1%($1.5B)
Single Cell Consumables21.1%($1.2B)
Spatial Consumables5.9%($324M)
Instruments5%($273M)
Spatial Instruments3.1%($167M)
Single Cell Instruments1.9%($106M)
Service1.3%($73M)
Licensing And Royalty Revenue1.2%($63M)
Revenue by Geography
Americas32.9%($1.1B)
US31.7%($1.0B)
EMEA14.1%($464M)
Asia Pacific10%($329M)
CN5.4%($179M)
Asia Pacific Excluding China4.6%($150M)
Americas Excluding United States1.2%($39M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001770787
ISINUS88025U1097
CUSIP88025U109
Phone925 401 7300
Address6230 Stoneridge Mall Road, Pleasanton, CA, 94588-3260, US
SEC EDGAR